EAVI2020 receives 6-month project extension
Funding body, European Commission recognises blight of COVID-19 on Horizon2020 clinical research
COVID-19 has had a considerable impact on the progress of EAVI2020’s clinical trial and lab work. Like many Horizon2020 projects involved in clinical trials, it was required to halt all lab work as a result of the pandemic and the European Commission (EC) have recognised this. It is anticipated that EAVI2020 clinical work can resume in the coming months, and the EAVI2020 consortium will use this compensatory time to continue the lab work when it is safe to return. The Consortium are very appreciated for this no-cost extension and they are positive that this will maximise the expected impacts of the EAVI2020 project.
EAVI2020 will thus have an expected project closure date in April 2021.
For further information, the European Commission has placed up-to-date information on their website regarding COVID-19 response and action.